Maze Therapeutics, Inc. · NASDAQ:MAZE
Coloma Jason V sold 22,638 Maze Therapeutics, Inc. shares (Form 4)
Traded Sep 2 to Sep 3, 2026 · Filed Sep 4, 2026
From Sep 2 to Sep 3, 2026, Coloma Jason V (Director, Chief Executive Officer) sold 22,638 Maze Therapeutics, Inc. shares at an average US$26.24 for US$594K, leaving 27,362 shares. Filed Sep 4, 2026 (Form 4).
- Sold
- 22,638 shares
- Price
- US$26.24 average (US$25.77 to US$27.12)
- Value
- US$594K
- Holding after
- 27,362 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Common Stock | Sale | 9,852 | US$26.38 | 40,148 | Direct |
| Sep 2, 2026 | Common Stock | Sale | 1,375 | US$27.12 | 38,773 | Direct |
| Sep 3, 2026 | Common Stock | Sale | 11,282 | US$26.01 | 27,491 | Direct |
| Sep 3, 2026 | Common Stock | Sale | 129 | US$25.77 | 27,362 | Direct |
Source
Related
- Maze Therapeutics, Inc.
- Coloma Jason V
- Maze Therapeutics, Inc. shareholders
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Coloma Jason V · Sep 3, 2026
- Form 4 · Coloma Jason V · Aug 5, 2026
- Form 4 · Coloma Jason V · Jul 2, 2026
- Form 4 · Coloma Jason V · Jun 24, 2026
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026
- Form 4 · Dandekar Atul · Sep 4, 2026